Table 2.
Treatment outcome, recurrence status, and adjuvant- and systemic therapy.
| n (%) | |
|---|---|
| Patients | 94 |
| Primary resection | 86 (91.5) |
| R0 | 39 (45.5) |
| R1 | 6 (7) |
| Rx | 41 (39.1) |
| Recurrence | |
| Local recurrence | 23 (26.7) |
| Metachronous metastasis | 26 (30.2) |
| No recurrence | 37 (43.0) |
| Adjuvant radiotherapy | 14 (16.3) |
| Local recurrence | 1 (7.1) |
| Metastatic recurrence | 5 (35.7) |
| Adjuvant systemic therapy | 0 (0) |
|
| |
| Systemic therapy | 28 (29.8) |
| Neoadjuvant | 2 (2.1) |
| Palliative | 24 (25.5) |
| Neoadjuvant and palliative | 2 (2.1) |
Treatments applied in 94 patients with SFT. R0: complete resection. R1: microscopic residual disease. Rx: unknown resection status.